Interestingly, RAB38, a new member of the RAB small G protein family that regulates intracellular vesicle trafficking [56], RAB27a [57], as well as RAB34 [58] have all been reported to confer a poor prognosis, associated with malignant progression and subtype preference in gliomas. Here, RAB34 is linked to central nervous system cancer.